Respiratory Syncytial Virus (RSV) Diagnostics Market
Respiratory Syncytial Virus (RSV) Diagnostics Market Analysis By Technology (RSV Molecular Diagnostics, Immunoassays, Differential Light Scattering, Artificial Intelligence, Liposomes, Flow Cytometry, Chromatography, Diagnostic Imaging), By End Users - Global Insights to 2031
Analysis of Respiratory Syncytial Virus (RSV) Diagnostics market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Market Outlook for Respiratory Syncytial Virus (RSV) Diagnostics
A newly published industry analysis by Fact.MR estimates revenue from the global respiratory syncytial virus (RSV) diagnostics market to reach US$ 1.3 Bn by 2031, surging at a CAGR of 9%. Demand for RSV diagnostic kits & assays to remain high and reach a valuation of US$ 720 Mn by the end of 2031.
Amongst the many factors credited to accelerating demand for respiratory syncytial virus diagnostics is rising burden of RSV infections, growing demand for molecular diagnostic tests, and increasing approvals of RSV diagnostic kits & assays.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Key Points Covered in Respiratory Syncytial Virus Diagnostics Industry Survey:
- Market Estimates and Forecasts (2016-2031)
- Key Drivers and Restraints Shaping Market Growth
- Segment-wise, Country-wise and Region-wise Analysis
- Competition Mapping and Benchmarking
- Market Share Analysis
- COVID-19 Impact on Demand for Respiratory Syncytial Virus Diagnostics and How to Navigate
- Recommendation on Key Winning Strategies
Respiratory Syncytial Virus Diagnostics Marketplace Analysis from 2016 to 2020 Vs Demand Outlook for 2021 to 2031
The market for respiratory syncytial virus diagnostics grew from US$ 575 Mn in 2017 to US$ 678 Mn in 2020, and is anticipated to top US$ 1.3 Bn by 2031.
Respiratory syncytial virus is a very common and contagious virus that infects the respiratory track of most children before 1-2 years of age. RSV is the most common cause of bronchiolitis and pneumonia. It also causes respiratory illness in adults, and it can occasionally cause serious infection that needs hospitalization due to breathing complications with bronchiolitis or pneumonia.
For diagnosis, doctors mostly rely on a blood or urine test to look for bacterial infection, chest X-ray for checking any signs of pneumonia, and a test of material scraped out from the patient’s nose or mouth.
Globally, cases of RSV infections are on the rise, which is fuelling demand for rapid diagnostic techniques. According to the Centre of Disease Control and Prevention (CDC), each year, on an average, RSV leads to the hospitalizations of around 1,32,000 - 1,72,000 children below the age of five, and the death of around 14,000 adults above the age of 65, in the United States alone.
As the clinical symptoms of RSV infections are indistinguishable from other respiratory infections, there is growing need for rapid, specific, and sensitive diagnostic techniques.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
How are Technological Advancements Aiding Demand Growth of RSV Diagnostics?
New technologies such as filament-based antibody detection assays, thin layer-based amperometric enzyme immunoassay (EIA), and multiplex virus testing are in the final stage of development.
Furthermore, nucleic acid amplification techniques and loop-mediated isothermal amplification will soon be aligned with point of care (POC) devices. This will allow testing to be performed using a one-step kit, which will require only the addition of a patient sample.
Also, the nanoparticle technology, which has the potential to bring about a four-fold improvement in viral detection as compared to RT-PCR, is under development.
Similarly, plasmonic detection techniques such as localized surface plasmon resonance (LSPR) spectroscopy (which uses metallic nanomaterials by exploiting physicochemical peculiarities) are under development with POC detection devices.
This is considered as a major development as methods such as LSPR spectroscopy offer rapid diagnostics and superior sensitivity & affordability as compared to techniques such as surface-enhanced Raman spectroscopy (SERS) and Polymerase Chain Reaction (PCR) coupled with electrospray ionization mass spectrometry (PCR-ESI-MS), which are not cost-effective, cumbersome to perform, and are more limited to research purposes.
Over the next few years, all the above-mentioned technologies are expected to be included in commercialized diagnostic methods. This is considered as a potential growth area for players involved in RSV diagnostics.
Why is Demand for Molecular Testing of RSV Infections on the Rise?
Demand for molecular testing of RSV infections is increasing in hospitals and reference laboratories. Moreover, a number of Clinical Laboratory Improvement Amendment (CLIA) waivers and U.S. FDA clearances are supporting the adoption of molecular diagnostic tests in physician offices and urgent care clinics.
Since RSV infections have a higher prevalence among infants and young children, adoption of molecular diagnostics is increasing as compared to immunoassays in this patient group.
Rapid immunoassays are preferred whenever a quick estimation of the infection is required in inpatient and outpatient settings as well as for community surveillance. However, for the confirmation of the infection, molecular diagnostic tests are deployed to better evaluate the entire course of infection.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What is the Regional Demand Outlook for RSV Diagnostics?
The global market for RSV diagnostics is dominated by North America, followed by Europe. North America will continue to dominate the landscape over the forecast period.
However, the respiratory syncytial virus diagnostics market in Asia Pacific is expected to witness higher gro wth across the assessment period. Increasing burden of infectious diseases such as RSV and focus of major players on emerging Asia Pacific countries are driving market growth in the region.
Country-wise Analysis
Why is China Emerging as an Epicentre for Market Players Involved in Respiratory Syncytial Virus Diagnostics?
In China, the RSV diagnostics market is expected to reach a valuation of US$ 253 Mn by 2031.
China, being the epicentre of the novel coronavirus disease, is expected to garner massive growth for RSV diagnostics. Besides, infant population is also on the rise in the country.
Strong steps by governments such as creating awareness about the respiratory syncytial virus through various initiatives are also expected to prove as a growth multiplier for the market in China.
Category-wise Analysis
Why Do Kits & Assays Account for the Largest Share in the Market for RSV Diagnostics?
Kits & assays account for more than 36% share of the global market for RSV diagnostics. Factors driving the growth of this segment include increasing infections of RSV in new-borns, infants, and young children, and growing demand for kits & assays for RSV diagnosis.
Due to ease of usage and quick accurate results, demand for RSV diagnostic kits & assays has been on the rise across the world.
What Has Been the Impact of COVID-19 on RSV Diagnostics?
The spread of COVID-19 has risen demand for rapid testing kits worldwide. As the novel coronavirus impacts the respiratory system, several companies are offering respiratory syncytial diagnostic test kits for testing COVID-19.
For instance, the U.S. FDA recently approved the use of Mesa Biotech’s Accula device for COVID-19, which gives results in around 30 minutes.
Use of such RSV diagnostic products for COVID-19 testing is expected to fuel the growth of the market substantially.
Competitive Landscape
The respiratory syncytial virus diagnostics landscape is highly fragmented in nature. Manufacturers are focusing on technological innovations for speeding up the diagnosis of the respiratory syncytial virus.
Frequent mergers and acquisitions also take place in the market. The acquisition of Sigma Aldrich by Merck KGaA is a classic example.
Respiratory Syncytial Virus Diagnostics Market Report Scope
|
Attribute |
Details |
|
Forecast Period |
2021-2031 |
|
Historical Data Available for |
2016-2020 |
|
Market Analysis |
US$ Mn for Value & ‘000 Units for Volume |
| Key Regions Covered |
|
|
Key Market Segments Covered |
|
| Key Market Segments Covered |
|
|
Key Companies Profiled
|
|
| Pricing |
Available upon Request |
Key Market Segments Covered in Respiratory Syncytial Virus Diagnostics Industry Research
-
By Technology
- RSV Molecular Diagnostics
- RSV Monoclonal Antibodies
- Immunoassays
- Differential Light Scattering
- Artificial Intelligence
- Liposomes
- Flow Cytometry
- Chromatography
- Diagnostic Imaging
- Gel Microdroplets
-
By End Users
- Respiratory Syncytial Virus Diagnostics at Hospitals
- Respiratory Syncytial Virus Diagnostics at Nursing Homes
- Respiratory Syncytial Virus Diagnostics at Commercial Laboratories
- Respiratory Syncytial Virus Diagnostics at Public Health Laboratories
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions/Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product modifications /Innovation 4. Key Success Factors 4.1. Strategic Developments 4.2. Key regulations 4.3. Product USPs /Technology 4.4. List of manufacturers and providers 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP outlook 5.1.2. Increasing R&D Expenditure 5.2. Forecast Factors - Relevance & Impact 5.2.1. New product launches 5.2.2. Cost of products 5.2.3. Increasing adoption of Respiratory Syncytial Virus (RSV) Diagnosticss 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. COVID19 Crisis Analysis 6.1.1. Current COVID19 Statistics and Probable Future Impact 6.1.2. Current GDP Projection and Probable Impact 6.1.3. Current Economic Projection as compared to 2008 Economic analysis 6.1.4. COVID19 and Impact Analysis 6.1.4.1. Revenue By Technology 6.1.4.2. Revenue By End User 6.1.4.3. Revenue By Country 6.1.5. 2020 Market Scenario 6.1.6. Quarter by Quarter Forecast 6.1.7. Projected Recovery Quarter 7. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Volume (Units) Analysis 2016-2020 and Forecast, 2021-2031 7.1. Historical Market Volume (Units) Analysis, 2016-2020 7.2. Current and Future Market Volume (Units) Projections, 2021-2031 7.2.1. Y-o-Y Growth Trend Analysis 8. Global Respiratory Syncytial Virus (RSV) Diagnostics Market - Pricing Analysis 8.1. Regional Pricing Analysis By Technology 8.2. Pricing Break-up 8.2.1. Manufacturer Level Pricing 8.2.2. Distributor Level Pricing 8.3. Global Average Pricing Analysis Benchmark 9. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Value Analysis 2016–2020 and Forecast, 2021-2031 9.1. Historical Market Value (US$ Mn) Analysis, 2016–2020 9.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031 9.2.1. Y-o-Y Growth Trend Analysis 9.2.2. Absolute $ Opportunity Analysis 10. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Analysis 2016–2020 and Forecast 2021-2031, by Technology 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) Analysis By Products & Services, 2016–2020 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technology, 2021-2031 10.3.1. Molecular Diagnostics 10.3.2. Monoclonal Antibodies 10.3.3. Immunoassays 10.3.4. Differential Light Scattering 10.3.5. Artificial Intelligence 10.3.6. Liposomes 10.3.7. Flow Cytometry 10.3.8. Chromatography 10.3.9. Diagnostic Imaging 10.3.10. Gel Microdroplets 10.4. Market Attractiveness Analysis By Technology 11. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Analysis 2016–2020 and Forecast 2021-2031, by End User 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Analysis By End User , 2016–2020 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User , 2021-2031 11.3.1. Hospitals 11.3.2. Nursing Homes 11.3.3. Commercial Laboratories 11.3.4. Public Health Laboratories 11.4. Market Attractiveness Analysis By End User 12. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Analysis 2016–2020 and Forecast 2021-2031, by Region 12.1. Introduction 12.2. Historical Market Size (US$ Mn) Analysis By Region, 2016–2020 12.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2021-2031 12.3.1. North America 12.3.2. Latin America 12.3.3. Europe 12.3.4. East Asia 12.3.5. South Asia 12.3.6. Oceania 12.3.7. Middle East and Africa (MEA) 12.4. Market Attractiveness Analysis By Region 13. North America Respiratory Syncytial Virus (RSV) Diagnostics Market Analysis 2016–2020 and Forecast 2021-2031 13.1. Introduction 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020 13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031 13.3.1. By Country 13.3.1.1. U.S. 13.3.1.2. Canada 13.3.2. By Technology 13.3.3. By End User 13.4. Market Attractiveness Analysis 13.5. Key Market Participants - Intensity Mapping 13.6. Drivers and Restraints - Impact Analysis 14. Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market Analysis 2016–2020 and Forecast 2021-2031 14.1. Introduction 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020 14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031 14.3.1. By Country 14.3.1.1. Brazil 14.3.1.2. Mexico 14.3.1.3. Argentina 14.3.1.4. Rest of Latin America 14.3.2. By Technology 14.3.3. By End User 14.4. Market Attractiveness Analysis 14.5. Key Market Participants - Intensity Mapping 14.6. Drivers and Restraints - Impact Analysis 15. Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Analysis 2016–2020 and Forecast 2021-2031 15.1. Introduction 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020 15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031 15.3.1. By Country 15.3.1.1. Germany 15.3.1.2. Italy 15.3.1.3. France 15.3.1.4. U.K. 15.3.1.5. Spain 15.3.1.6. Russia 15.3.1.7. Rest of Europe 15.3.2. By Technology 15.3.3. By End User 15.4. Market Attractiveness Analysis 15.5. Key Market Participants - Intensity Mapping 15.6. Drivers and Restraints - Impact Analysis 16. South Asia Respiratory Syncytial Virus (RSV) Diagnostics Market Analysis 2016–2020 and Forecast 2021-2031 16.1. Introduction 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020 16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031 16.3.1. By Country 16.3.1.1. India 16.3.1.2. Thailand 16.3.1.3. Indonesia 16.3.1.4. Malaysia 16.3.1.5. Rest of South Asia 16.3.2. By Technology 16.3.3. By End User 16.4. Market Attractiveness Analysis 16.5. Key Market Participants - Intensity Mapping 16.6. Drivers and Restraints - Impact Analysis 17. East Asia Respiratory Syncytial Virus (RSV) Diagnostics Market Analysis 2016–2020 and Forecast 2021-2031 17.1. Introduction 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020 17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031 17.3.1. By Country 17.3.1.1. China 17.3.1.2. Japan 17.3.1.3. South Korea 17.3.1.4. Rest of East Asia 17.3.2. By Technology 17.3.3. By End User 17.4. Market Attractiveness Analysis 17.5. Key Market Participants - Intensity Mapping 17.6. Drivers and Restraints - Impact Analysis 18. Oceania Respiratory Syncytial Virus (RSV) Diagnostics Market Analysis 2016–2020 and Forecast 2021-2031 18.1. Introduction 18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020 18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031 18.3.1. By Country 18.3.1.1. Australia 18.3.1.2. New Zealand 18.3.2. By Technology 18.3.3. By End User 18.4. Market Attractiveness Analysis 18.5. Key Market Participants - Intensity Mapping 18.6. Drivers and Restraints - Impact Analysis 19. Middle East and Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Analysis 2016–2020 and Forecast 2021-2031 19.1. Introduction 19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020 19.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031 19.3.1. By Country 19.3.1.1. GCC Countries 19.3.1.2. South Africa 19.3.1.3. Rest of Middle East and Africa 19.3.2. By Technology 19.3.3. By End User 19.4. Market Attractiveness Analysis 19.5. Drivers and Restraints - Impact Analysis 20. Key and Emerging Countries Respiratory Syncytial Virus (RSV) Diagnostics Market Analysis 2016–2020 and Forecast 2021-2031 20.1. Introduction 20.1.1. Market Value Proportion Analysis, By Key Countries 20.1.2. Global Vs. Country Growth Comparison 20.2. U.S. Respiratory Syncytial Virus (RSV) Diagnostics Market Analysis 20.2.1. By Technology 20.2.2. By End User 20.3. Canada Respiratory Syncytial Virus (RSV) Diagnostics Market Analysis 20.3.1. By Technology 20.3.2. By End User 20.4. Mexico Respiratory Syncytial Virus (RSV) Diagnostics Market Analysis 20.4.1. By Technology 20.4.2. By End User 20.5. Brazil Respiratory Syncytial Virus (RSV) Diagnostics Market Analysis 20.5.1. By Technology 20.5.2. By End User 20.6. U.K. Respiratory Syncytial Virus (RSV) Diagnostics Market Analysis 20.6.1. By Technology 20.6.2. By End User 20.7. Germany Respiratory Syncytial Virus (RSV) Diagnostics Market Analysis 20.7.1. By Technology 20.7.2. By End User 20.8. France Respiratory Syncytial Virus (RSV) Diagnostics Market Analysis 20.8.1. By Technology 20.8.2. By End User 20.9. Italy Respiratory Syncytial Virus (RSV) Diagnostics Market Analysis 20.9.1. By Technology 20.9.2. By End User 20.10. Spain Respiratory Syncytial Virus (RSV) Diagnostics Market Analysis 20.10.1. By Technology 20.10.2. By End User 20.11. BENELUX Respiratory Syncytial Virus (RSV) Diagnostics Market Analysis 20.11.1. By Technology 20.11.2. By End User 20.12. Russia Respiratory Syncytial Virus (RSV) Diagnostics Market Analysis 20.12.1. By Technology 20.12.2. By End User 20.13. China Respiratory Syncytial Virus (RSV) Diagnostics Market Analysis 20.13.1. By Technology 20.13.2. By End User 20.14. Japan Respiratory Syncytial Virus (RSV) Diagnostics Market Analysis 20.14.1. By Technology 20.14.2. By End User 20.15. South Korea Respiratory Syncytial Virus (RSV) Diagnostics Market Analysis 20.15.1. By Technology 20.15.2. By End User 20.16. India Respiratory Syncytial Virus (RSV) Diagnostics Market Analysis 20.16.1. By Technology 20.16.2. By End User 20.17. ASEAN Respiratory Syncytial Virus (RSV) Diagnostics Market Analysis 20.17.1. By Technology 20.17.2. By End User 20.18. Australia Respiratory Syncytial Virus (RSV) Diagnostics Market Analysis 20.18.1. By Technology 20.18.2. By End User 20.19. New Zealand Respiratory Syncytial Virus (RSV) Diagnostics Market Analysis 20.19.1. By Technology 20.19.2. By End User 20.20. GCC Countries Respiratory Syncytial Virus (RSV) Diagnostics Market Analysis 20.20.1. By Technology 20.20.2. By End User 20.21. Turkey Respiratory Syncytial Virus (RSV) Diagnostics Market Analysis 20.21.1. By Technology 20.21.2. By End User 20.22. South Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Analysis 20.22.1. By Technology 20.22.2. By End User 21. Market Structure Analysis 21.1. Market Analysis by Tier of Companies 21.2. Market Concentration 21.3. Market Share Analysis of Top Players 21.4. Market Presence Analysis 21.4.1. By Regional footprint of Players 21.4.2. Product foot print by Players 21.4.3. Channel Foot Print by Players 22. Competition Analysis 22.1. Competition Dashboard 22.2. Competition Benchmarking 22.3. Competition Deep dive 22.3.1. BioMérieux 22.3.1.1. Overview 22.3.1.2. Product Portfolio 22.3.1.3. Profitability by Market Segments (Product/Channel/Region) 22.3.1.4. Sales Footprint 22.3.1.5. Strategy Overview 22.3.1.5.1. Marketing Strategy 22.3.1.5.2. Product Strategy 22.3.1.5.3. Channel Strategy 22.3.2. Abbott 22.3.2.1. Overview 22.3.2.2. Product Portfolio 22.3.2.3. Profitability by Market Segments (Product/Channel/Region) 22.3.2.4. Sales Footprint 22.3.2.5. Strategy Overview 22.3.2.5.1. Marketing Strategy 22.3.2.5.2. Product Strategy 22.3.2.5.3. Channel Strategy 22.3.3. Roche, BD 22.3.3.1. Overview 22.3.3.2. Product Portfolio 22.3.3.3. Profitability by Market Segments (Product/Channel/Region) 22.3.3.4. Sales Footprint 22.3.3.5. Strategy Overview 22.3.3.5.1. Marketing Strategy 22.3.3.5.2. Product Strategy 22.3.3.5.3. Channel Strategy 22.3.4. Thermo Fisher 22.3.4.1. Overview 22.3.4.2. Product Portfolio 22.3.4.3. Profitability by Market Segments (Product/Channel/Region) 22.3.4.4. Sales Footprint 22.3.4.5. Strategy Overview 22.3.4.5.1. Marketing Strategy 22.3.4.5.2. Product Strategy 22.3.4.5.3. Channel Strategy 22.3.5. Luminex 22.3.5.1. Overview 22.3.5.2. Product Portfolio 22.3.5.3. Profitability by Market Segments (Product/Channel/Region) 22.3.5.4. Sales Footprint 22.3.5.5. Strategy Overview 22.3.5.5.1. Marketing Strategy 22.3.5.5.2. Product Strategy 22.3.5.5.3. Channel Strategy 22.3.6. Danaher 22.3.6.1. Overview 22.3.6.2. Product Portfolio 22.3.6.3. Profitability by Market Segments (Product/Channel/Region) 22.3.6.4. Sales Footprint 22.3.6.5. Strategy Overview 22.3.6.5.1. Marketing Strategy 22.3.6.5.2. Product Strategy 22.3.6.5.3. Channel Strategy 22.3.7. Biocartis 22.3.7.1. Overview 22.3.7.2. Product Portfolio 22.3.7.3. Profitability by Market Segments (Product/Channel/Region) 22.3.7.4. Sales Footprint 22.3.7.5. Strategy Overview 22.3.7.5.1. Marketing Strategy 22.3.7.5.2. Product Strategy 22.3.7.5.3. Channel Strategy 22.3.8. Hologic 22.3.8.1. Overview 22.3.8.2. Product Portfolio 22.3.8.3. Profitability by Market Segments (Product/Channel/Region) 22.3.8.4. Sales Footprint 22.3.8.5. Strategy Overview 22.3.8.5.1. Marketing Strategy 22.3.8.5.2. Product Strategy 22.3.8.5.3. Channel Strategy 23. Assumptions and Acronyms Used 24. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Respiratory Syncytial Virus (RSV) Diagnostics Market Volume (‘000 Units) Analysis and Opportunity Assessment 2016–2031, By Technology
Table 02: Global Respiratory Syncytial Virus (RSV) Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Technology
Table 03: Global Respiratory Syncytial Virus (RSV) Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By End User
Table 04: Global Respiratory Syncytial Virus (RSV) Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Region
Table 05: North America Respiratory Syncytial Virus (RSV) Diagnostics Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country
Table 06: North America Respiratory Syncytial Virus (RSV) Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Technology
Table 07: North America Respiratory Syncytial Virus (RSV) Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By End User
Table 08: Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country
Table 09: Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Technology
Table 10: Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By End User
Table 11: Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country
Table 12: Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Technology
Table 13: Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By End User
Table 14: South Asia Respiratory Syncytial Virus (RSV) Diagnostics Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country
Table 15: South Asia Respiratory Syncytial Virus (RSV) Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Technology
Table 16: South Asia Respiratory Syncytial Virus (RSV) Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By End User
Table 17: East Asia Respiratory Syncytial Virus (RSV) Diagnostics Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country
Table 18: East Asia Respiratory Syncytial Virus (RSV) Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Technology
Table 19: East Asia Respiratory Syncytial Virus (RSV) Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By End User
Table 20: Oceania Respiratory Syncytial Virus (RSV) Diagnostics Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country
Table 21: Oceania Respiratory Syncytial Virus (RSV) Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Technology
Table 22: Oceania Respiratory Syncytial Virus (RSV) Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By End User
Table 23: Middle East and Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country
Table 24: Middle East and Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Technology
Table 25: Middle East and Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By End User
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Respiratory Syncytial Virus (RSV) Diagnostics Market Volume (in 000' Units) Analysis, 2016-2020
Figure 02: Global Respiratory Syncytial Virus (RSV) Diagnostics Market Volume Forecast (in 000' Units), 2021-2031
Figure 03: Respiratory Syncytial Virus (RSV) Diagnostics Pricing Analysis (US$) Per Product, By Region, 2020
Figure 04: Respiratory Syncytial Virus (RSV) Diagnostics Pricing Analysis (US$) Per Product, By Region, 2020
Figure 05: Global Respiratory Syncytial Virus (RSV) Diagnostics Market Value Analysis (US$ Mn), 2016-2020
Figure 06: Global Respiratory Syncytial Virus (RSV) Diagnostics Market Value Forecast (US$ Mn), 2021-2031
Figure 07: Global Respiratory Syncytial Virus (RSV) Diagnostics Market Absolute $ Opportunity, 2021-2031
Figure 08: Global Respiratory Syncytial Virus (RSV) Diagnostics Market Share Analysis (%), By Technology, 2021-2031
Figure 09: Global Respiratory Syncytial Virus (RSV) Diagnostics Market Y-o-Y Analysis (%), By Technology, 2021-2031
Figure 10: Global Respiratory Syncytial Virus (RSV) Diagnostics Market Attractiveness Analysis by Technology, 2021-2031
Figure 11: Global Respiratory Syncytial Virus (RSV) Diagnostics Market Share Analysis (%), By End User, 2021-2031
Figure 12: Global Respiratory Syncytial Virus (RSV) Diagnostics Market Y-o-Y Analysis (%), By End User, 2021-2031
Figure 13: Global Respiratory Syncytial Virus (RSV) Diagnostics Market Attractiveness Analysis by End User, 2021-2031
Figure 14: Global Respiratory Syncytial Virus (RSV) Diagnostics Market Share Analysis (%), By Region, 2021-2031
Figure 15: Global Respiratory Syncytial Virus (RSV) Diagnostics Market Y-o-Y Analysis (%), By Region, 2021-2031
Figure 16: Global Respiratory Syncytial Virus (RSV) Diagnostics Market Attractiveness Analysis by Region, 2021-2031
Figure 17: North America Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By Technology, 2021 (E)
Figure 18: North America Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By End User, 2021 (E)
Figure 19: North America Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By Country, 2021 (E)
Figure 20: North America Respiratory Syncytial Virus (RSV) Diagnostics Market Value Analysis (US$ Mn), 2016-2020
Figure 21: North America Respiratory Syncytial Virus (RSV) Diagnostics Market Value Forecast (US$ Mn), 2021-2031
Figure 22: North America Respiratory Syncytial Virus (RSV) Diagnostics Market Attractiveness Analysis by Technology, 2021-2031
Figure 23: North America Respiratory Syncytial Virus (RSV) Diagnostics Market Attractiveness Analysis by End User, 2021-2031
Figure 24: North America Respiratory Syncytial Virus (RSV) Diagnostics Market Attractiveness Analysis by Country, 2021-2031
Figure 25: Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By Technology, 2021 (E)
Figure 26: Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By End User, 2021 (E)
Figure 27: Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By Country, 2021 (E)
Figure 28: Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market Value Analysis (US$ Mn), 2016-2020
Figure 29: Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market Value Forecast (US$ Mn), 2021-2031
Figure 30: Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market Attractiveness Analysis by Technology, 2021-2031
Figure 31: Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market Attractiveness Analysis by End User, 2021-2031
Figure 32: Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market Attractiveness Analysis by Country, 2021-2031
Figure 33: Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By Technology, 2021 (E)
Figure 34: Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By End User, 2021 (E)
Figure 35: Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By Country, 2021 (E)
Figure 36: Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Value Analysis (US$ Mn), 2016-2020
Figure 37: Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Value Forecast (US$ Mn), 2021-2031
Figure 38: Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Attractiveness Analysis by Technology, 2021-2031
Figure 39: Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Attractiveness Analysis by End User, 2021-2031
Figure 40: Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Attractiveness Analysis by Country, 2021-2031
Figure 41: South Asia Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By Technology, 2021 (E)
Figure 42: South Asia Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By End User, 2021 (E)
Figure 43: South Asia Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By Country, 2021 (E)
Figure 44: South Asia Respiratory Syncytial Virus (RSV) Diagnostics Market Value Analysis (US$ Mn), 2016-2020
Figure 45: South Asia Respiratory Syncytial Virus (RSV) Diagnostics Market Value Forecast (US$ Mn), 2021-2031
Figure 46: South Asia Respiratory Syncytial Virus (RSV) Diagnostics Market Attractiveness Analysis by Technology, 2021-2031
Figure 47: South Asia Respiratory Syncytial Virus (RSV) Diagnostics Market Attractiveness Analysis by End User, 2021-2031
Figure 48: South Asia Respiratory Syncytial Virus (RSV) Diagnostics Market Attractiveness Analysis by Country, 2021-2031
Figure 49: East Asia Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By Technology, 2021 (E)
Figure 50: East Asia Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By End User, 2021 (E)
Figure 51: East Asia Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By Country, 2021 (E)
Figure 52: East Asia Respiratory Syncytial Virus (RSV) Diagnostics Market Value Analysis (US$ Mn), 2016-2020
Figure 53: East Asia Respiratory Syncytial Virus (RSV) Diagnostics Market Value Forecast (US$ Mn), 2021-2031
Figure 54: East Asia Respiratory Syncytial Virus (RSV) Diagnostics Market Attractiveness Analysis by Technology, 2021-2031
Figure 55: East Asia Respiratory Syncytial Virus (RSV) Diagnostics Market Attractiveness Analysis by End User, 2021-2031
Figure 56: East Asia Respiratory Syncytial Virus (RSV) Diagnostics Market Attractiveness Analysis by Country, 2021-2031
Figure 57: Oceania Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By Technology, 2021 (E)
Figure 58: Oceania Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By End User, 2021 (E)
Figure 59: Oceania Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By Country, 2021 (E)
Figure 60: Oceania Respiratory Syncytial Virus (RSV) Diagnostics Market Value Analysis (US$ Mn), 2016-2020
Figure 61: Oceania Respiratory Syncytial Virus (RSV) Diagnostics Market Value Forecast (US$ Mn), 2021-2031
Figure 62: Oceania Respiratory Syncytial Virus (RSV) Diagnostics Market Attractiveness Analysis by Technology, 2021-2031
Figure 63: Oceania Respiratory Syncytial Virus (RSV) Diagnostics Market Attractiveness Analysis by End User, 2021-2031
Figure 64: Oceania Respiratory Syncytial Virus (RSV) Diagnostics Market Attractiveness Analysis by Country, 2021-2031
Figure 65: Middle East and Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By Technology, 2021 (E)
Figure 66: Middle East and Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By End User, 2021 (E)
Figure 67: Middle East and Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By Country, 2021 (E)
Figure 68: Middle East and Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Value Analysis (US$ Mn), 2016-2020
Figure 69: Middle East and Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Value Forecast (US$ Mn), 2021-2031
Figure 70: Middle East and Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Attractiveness Analysis by Technology, 2021-2031
Figure 71: Middle East and Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Attractiveness Analysis by End User, 2021-2031
Figure 72: Middle East and Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Attractiveness Analysis by Country, 2021-2031
Figure 73: U. S. Respiratory Syncytial Virus (RSV) Diagnostics Market Value Analysis (US$ Mn), 2021 & 2031
Figure 74: U. S. Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By Technology, 2021 (E)
Figure 75: U. S. Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By End User, 2021 (E)
Figure 76: Canada Respiratory Syncytial Virus (RSV) Diagnostics Market Value Analysis (US$ Mn), 2021 & 2031
Figure 77: Canada Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By Technology, 2021 (E)
Figure 78: Canada Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By End User, 2021 (E)
Figure 79: Mexico Respiratory Syncytial Virus (RSV) Diagnostics Market Value Analysis (US$ Mn), 2021 & 2031
Figure 80: Mexico Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By Technology, 2021 (E)
Figure 81: Mexico Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By End User, 2021 (E)
Figure 82: Brazil Respiratory Syncytial Virus (RSV) Diagnostics Market Value Analysis (US$ Mn), 2021 & 2031
Figure 83: Brazil Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By Technology, 2021 (E)
Figure 84: Brazil Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By End User, 2021 (E)
Figure 85: U. K. Respiratory Syncytial Virus (RSV) Diagnostics Market Value Analysis (US$ Mn), 2021 & 2031
Figure 86: U. K. Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By Technology, 2021 (E)
Figure 87: U. K. Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By End User, 2021 (E)
Figure 88: Germany Respiratory Syncytial Virus (RSV) Diagnostics Market Value Analysis (US$ Mn), 2021 & 2031
Figure 89: Germany Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By Technology, 2021 (E)
Figure 90: Germany Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By End User, 2021 (E)
Figure 91: France Respiratory Syncytial Virus (RSV) Diagnostics Market Value Analysis (US$ Mn), 2021 & 2031
Figure 92: France Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By Technology, 2021 (E)
Figure 93: France Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By End User, 2021 (E)
Figure 94: Italy Respiratory Syncytial Virus (RSV) Diagnostics Market Value Analysis (US$ Mn), 2021 & 2031
Figure 95: Italy Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By Technology, 2021 (E)
Figure 96: Italy Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By End User, 2021 (E)
Figure 97: Spain Respiratory Syncytial Virus (RSV) Diagnostics Market Value Analysis (US$ Mn), 2021 & 2031
Figure 98: Spain Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By Technology, 2021 (E)
Figure 99: Spain Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By End User, 2021 (E)
Figure 100: Russia Respiratory Syncytial Virus (RSV) Diagnostics Market Value Analysis (US$ Mn), 2021 & 2031
Figure 101: Russia Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By Technology, 2021 (E)
Figure 102: Russia Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By End User, 2021 (E)
Figure 103: China Respiratory Syncytial Virus (RSV) Diagnostics Market Value Analysis (US$ Mn), 2021 & 2031
Figure 104: China Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By Technology, 2021 (E)
Figure 105: China Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By End User, 2021 (E)
Figure 106: Japan Respiratory Syncytial Virus (RSV) Diagnostics Market Value Analysis (US$ Mn), 2021 & 2031
Figure 107: Japan Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By Technology, 2021 (E)
Figure 108: Japan Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By End User, 2021 (E)
Figure 109: South Korea Respiratory Syncytial Virus (RSV) Diagnostics Market Value Analysis (US$ Mn), 2021 & 2031
Figure 110: South Korea Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By Technology, 2021 (E)
Figure 111: South Korea Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By End User, 2021 (E)
Figure 112: India Respiratory Syncytial Virus (RSV) Diagnostics Market Value Analysis (US$ Mn), 2021 & 2031
Figure 113: India Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By Technology, 2021 (E)
Figure 114: India Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By End User, 2021 (E)
Figure 115: ASEAN Respiratory Syncytial Virus (RSV) Diagnostics Market Value Analysis (US$ Mn), 2021 & 2031
Figure 116: ASEAN Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By Technology, 2021 (E)
Figure 117: ASEAN Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By End User, 2021 (E)
Figure 118: Australia Respiratory Syncytial Virus (RSV) Diagnostics Market Value Analysis (US$ Mn), 2021 & 2031
Figure 119: Australia Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By Technology, 2021 (E)
Figure 120: Australia Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By End User, 2021 (E)
Figure 121: New Zealand Respiratory Syncytial Virus (RSV) Diagnostics Market Value Analysis (US$ Mn), 2021 & 2031
Figure 122: New Zealand Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By Technology, 2021 (E)
Figure 123: New Zealand Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By End User, 2021 (E)
Figure 124: GCC Countries Respiratory Syncytial Virus (RSV) Diagnostics Market Value Analysis (US$ Mn), 2021 & 2031
Figure 125: GCC Countries Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By Technology, 2021 (E)
Figure 126: GCC Countries Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By End User, 2021 (E)
Figure 127: Turkey Respiratory Syncytial Virus (RSV) Diagnostics Market Value Analysis (US$ Mn), 2021 & 2031
Figure 128: Turkey Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By Technology, 2021 (E)
Figure 129: Turkey Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By End User, 2021 (E)
Figure 130: South Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Value Analysis (US$ Mn), 2021 & 2031
Figure 131: South Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By Technology, 2021 (E)
Figure 132: South Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Value Share, By End User, 2021 (E)
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the projected market size for respiratory syncytial virus diagnostics?
The global respiratory syncytial virus (RSV) diagnostics market is slated to reach US$ 1.3 Bn by 2031-end.
What is the anticipated CAGR for the RSV diagnostics market through 2031?
The market for RSV diagnostics is anticipated to surge at a CAGR of 9% from 2021 to 2031.
How is demand for RSV diagnostics shaping up in China?
Revenue from RSV diagnostics in China is expected to top US$ 253 Mn by 2031.
What are the key driving factors for the demand growth of RSV diagnostics?
Rising prevalence of chronic diseases, including respiratory disorders, in the neonatal population and growing awareness among parents are driving market growth.
Who are the top market players providing RSV diagnostic products?
Luminex, Hologic, Danaher, Thermo Fisher Scientific, Biomérieux, and Fast Track Diagnostics are the top players operating in this industry.
Which type of RSV diagnostic test dominates the global market?
RSV diagnostic kits & assays are slated to dominate the global market over the next ten years.
Respiratory Syncytial Virus (RSV) Diagnostics Market